Global Meningococcal Polysaccharide Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Meningococcal Polysaccharide Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Meningococcal Polysaccharide Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Meningococcal Polysaccharide Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Meningococcal Polysaccharide Vaccine Segment by Type

2.2.1 Polysaccharide Meningtitis AC

2.2.2 Meningitis ACYW

2.3 Meningococcal Polysaccharide Vaccine Sales by Type

2.3.1 Global Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Meningococcal Polysaccharide Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Meningococcal Polysaccharide Vaccine Sale Price by Type (2017-2022)

2.4 Meningococcal Polysaccharide Vaccine Segment by Application

2.4.1 6 Months-15Year

2.4.2 over 3 Year

2.4.3 over 2 Year

2.4.4 over 3 Months

2.5 Meningococcal Polysaccharide Vaccine Sales by Application

2.5.1 Global Meningococcal Polysaccharide Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Meningococcal Polysaccharide Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Meningococcal Polysaccharide Vaccine Sale Price by Application (2017-2022)

3 Global Meningococcal Polysaccharide Vaccine by Company

3.1 Global Meningococcal Polysaccharide Vaccine Breakdown Data by Company

3.1.1 Global Meningococcal Polysaccharide Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Meningococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Meningococcal Polysaccharide Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Meningococcal Polysaccharide Vaccine Revenue by Company (2020-2022)

3.2.2 Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Meningococcal Polysaccharide Vaccine Sale Price by Company

3.4 Key Manufacturers Meningococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Meningococcal Polysaccharide Vaccine Product Location Distribution

3.4.2 Players Meningococcal Polysaccharide Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Meningococcal Polysaccharide Vaccine by Geographic Region

4.1 World Historic Meningococcal Polysaccharide Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Meningococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Meningococcal Polysaccharide Vaccine Annual Revenue by Geographic Region

4.2 World Historic Meningococcal Polysaccharide Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Meningococcal Polysaccharide Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Meningococcal Polysaccharide Vaccine Annual Revenue by Country/Region

4.3 Americas Meningococcal Polysaccharide Vaccine Sales Growth

4.4 APAC Meningococcal Polysaccharide Vaccine Sales Growth

4.5 Europe Meningococcal Polysaccharide Vaccine Sales Growth

4.6 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Growth

5 Americas

5.1 Americas Meningococcal Polysaccharide Vaccine Sales by Country

5.1.1 Americas Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)

5.1.2 Americas Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)

5.2 Americas Meningococcal Polysaccharide Vaccine Sales by Type

5.3 Americas Meningococcal Polysaccharide Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Meningococcal Polysaccharide Vaccine Sales by Region

6.1.1 APAC Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022)

6.1.2 APAC Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022)

6.2 APAC Meningococcal Polysaccharide Vaccine Sales by Type

6.3 APAC Meningococcal Polysaccharide Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Meningococcal Polysaccharide Vaccine by Country

7.1.1 Europe Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)

7.1.2 Europe Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)

7.2 Europe Meningococcal Polysaccharide Vaccine Sales by Type

7.3 Europe Meningococcal Polysaccharide Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Meningococcal Polysaccharide Vaccine by Country

8.1.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Type

8.3 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Meningococcal Polysaccharide Vaccine

10.3 Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine

10.4 Industry Chain Structure of Meningococcal Polysaccharide Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Meningococcal Polysaccharide Vaccine Distributors

11.3 Meningococcal Polysaccharide Vaccine Customer

12 World Forecast Review for Meningococcal Polysaccharide Vaccine by Geographic Region

12.1 Global Meningococcal Polysaccharide Vaccine Market Size Forecast by Region

12.1.1 Global Meningococcal Polysaccharide Vaccine Forecast by Region (2023-2028)

12.1.2 Global Meningococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Meningococcal Polysaccharide Vaccine Forecast by Type

12.7 Global Meningococcal Polysaccharide Vaccine Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Meningococcal Polysaccharide Vaccine Product Offered

13.1.3 Sanofi Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Bio-Med

13.2.1 Bio-Med Company Information

13.2.2 Bio-Med Meningococcal Polysaccharide Vaccine Product Offered

13.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bio-Med Main Business Overview

13.2.5 Bio-Med Latest Developments

13.3 CanSinoBIO

13.3.1 CanSinoBIO Company Information

13.3.2 CanSinoBIO Meningococcal Polysaccharide Vaccine Product Offered

13.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CanSinoBIO Main Business Overview

13.3.5 CanSinoBIO Latest Developments

13.4 Walvax Biotechnology

13.4.1 Walvax Biotechnology Company Information

13.4.2 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product Offered

13.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Walvax Biotechnology Main Business Overview

13.4.5 Walvax Biotechnology Latest Developments

13.5 Chongqing Zhifei Biological

13.5.1 Chongqing Zhifei Biological Company Information

13.5.2 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product Offered

13.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Chongqing Zhifei Biological Main Business Overview

13.5.5 Chongqing Zhifei Biological Latest Developments

13.6 Chengdu Kanghua Biological Products

13.6.1 Chengdu Kanghua Biological Products Company Information

13.6.2 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product Offered

13.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Chengdu Kanghua Biological Products Main Business Overview

13.6.5 Chengdu Kanghua Biological Products Latest Developments

13.7 Changsheng Biotechnology

13.7.1 Changsheng Biotechnology Company Information

13.7.2 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product Offered

13.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Changsheng Biotechnology Main Business Overview

13.7.5 Changsheng Biotechnology Latest Developments

13.8 CanSinoBIO

13.8.1 CanSinoBIO Company Information

13.8.2 CanSinoBIO Meningococcal Polysaccharide Vaccine Product Offered

13.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 CanSinoBIO Main Business Overview

13.8.5 CanSinoBIO Latest Developments

14 Research Findings and Conclusion

Table 1. Meningococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Meningococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Polysaccharide Meningtitis AC

Table 4. Major Players of Meningitis ACYW

Table 5. Global Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)

Table 6. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Meningococcal Polysaccharide Vaccine Sale Price by Type (2017-2022) & (US$/Dose)

Table 10. Global Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)

Table 11. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2022)

Table 13. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Meningococcal Polysaccharide Vaccine Sale Price by Application (2017-2022) & (US$/Dose)

Table 15. Global Meningococcal Polysaccharide Vaccine Sales by Company (2020-2022) & (K Doses)

Table 16. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Meningococcal Polysaccharide Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Meningococcal Polysaccharide Vaccine Sale Price by Company (2020-2022) & (US$/Dose)

Table 20. Key Manufacturers Meningococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area

Table 21. Players Meningococcal Polysaccharide Vaccine Products Offered

Table 22. Meningococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Meningococcal Polysaccharide Vaccine Sales by Geographic Region (2017-2022) & (K Doses)

Table 26. Global Meningococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Meningococcal Polysaccharide Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Meningococcal Polysaccharide Vaccine Sales by Country/Region (2017-2022) & (K Doses)

Table 30. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Meningococcal Polysaccharide Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Doses)

Table 34. Americas Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)

Table 38. Americas Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)

Table 40. Americas Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Doses)

Table 42. APAC Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)

Table 46. APAC Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)

Table 48. APAC Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Doses)

Table 50. Europe Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)

Table 54. Europe Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)

Table 56. Europe Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Doses)

Table 58. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)

Table 62. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)

Table 64. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Meningococcal Polysaccharide Vaccine

Table 66. Key Market Challenges & Risks of Meningococcal Polysaccharide Vaccine

Table 67. Key Industry Trends of Meningococcal Polysaccharide Vaccine

Table 68. Meningococcal Polysaccharide Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Meningococcal Polysaccharide Vaccine Distributors List

Table 71. Meningococcal Polysaccharide Vaccine Customer List

Table 72. Global Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Doses)

Table 73. Global Meningococcal Polysaccharide Vaccine Sales Market Forecast by Region

Table 74. Global Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 77. Americas Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Doses)

Table 79. APAC Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 81. Europe Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Doses)

Table 85. Global Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Meningococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Doses)

Table 89. Global Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Meningococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Meningococcal Polysaccharide Vaccine Product Offered

Table 94. Sanofi Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. Bio-Med Basic Information, Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Bio-Med Meningococcal Polysaccharide Vaccine Product Offered

Table 99. Bio-Med Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 100. Bio-Med Main Business

Table 101. Bio-Med Latest Developments

Table 102. CanSinoBIO Basic Information, Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. CanSinoBIO Meningococcal Polysaccharide Vaccine Product Offered

Table 104. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 105. CanSinoBIO Main Business

Table 106. CanSinoBIO Latest Developments

Table 107. Walvax Biotechnology Basic Information, Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product Offered

Table 109. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 110. Walvax Biotechnology Main Business

Table 111. Walvax Biotechnology Latest Developments

Table 112. Chongqing Zhifei Biological Basic Information, Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product Offered

Table 114. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 115. Chongqing Zhifei Biological Main Business

Table 116. Chongqing Zhifei Biological Latest Developments

Table 117. Chengdu Kanghua Biological Products Basic Information, Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product Offered

Table 119. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 120. Chengdu Kanghua Biological Products Main Business

Table 121. Chengdu Kanghua Biological Products Latest Developments

Table 122. Changsheng Biotechnology Basic Information, Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product Offered

Table 124. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 125. Changsheng Biotechnology Main Business

Table 126. Changsheng Biotechnology Latest Developments

Table 127. CanSinoBIO Basic Information, Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. CanSinoBIO Meningococcal Polysaccharide Vaccine Product Offered

Table 129. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 130. CanSinoBIO Main Business

Table 131. CanSinoBIO Latest Developments

List of Figures

Figure 1. Picture of Meningococcal Polysaccharide Vaccine

Figure 2. Meningococcal Polysaccharide Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Meningococcal Polysaccharide Vaccine Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Meningococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Meningococcal Polysaccharide Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Polysaccharide Meningtitis AC

Figure 10. Product Picture of Meningitis ACYW

Figure 11. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Type in 2021

Figure 12. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Meningococcal Polysaccharide Vaccine Consumed in 6 Months-15Year

Figure 14. Global Meningococcal Polysaccharide Vaccine Market: 6 Months-15Year (2017-2022) & (K Doses)

Figure 15. Meningococcal Polysaccharide Vaccine Consumed in over 3 Year

Figure 16. Global Meningococcal Polysaccharide Vaccine Market: over 3 Year (2017-2022) & (K Doses)

Figure 17. Meningococcal Polysaccharide Vaccine Consumed in over 2 Year

Figure 18. Global Meningococcal Polysaccharide Vaccine Market: over 2 Year (2017-2022) & (K Doses)

Figure 19. Meningococcal Polysaccharide Vaccine Consumed in over 3 Months

Figure 20. Global Meningococcal Polysaccharide Vaccine Market: over 3 Months (2017-2022) & (K Doses)

Figure 21. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

Figure 22. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Application in 2021

Figure 23. Meningococcal Polysaccharide Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Company in 2021

Figure 25. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2021

Figure 27. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)

Figure 28. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Country/Region in 2021

Figure 29. Americas Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Doses)

Figure 30. Americas Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. APAC Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Doses)

Figure 32. APAC Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Europe Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Doses)

Figure 34. Europe Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales 2017-2022 (K Doses)

Figure 36. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)

Figure 37. Americas Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021

Figure 38. Americas Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021

Figure 39. United States Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2021

Figure 44. APAC Meningococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2021

Figure 45. China Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021

Figure 52. Europe Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021

Figure 53. Germany Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021

Figure 60. Egypt Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Meningococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Meningococcal Polysaccharide Vaccine in 2021

Figure 66. Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine

Figure 67. Industry Chain Structure of Meningococcal Polysaccharide Vaccine

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles